Cover Image
市場調查報告書

栓塞保護裝置的全球市場預測 2023年:遠位過濾器、遠位閉塞、近位閉塞

Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 606413
出版日期 內容資訊 英文 174 Pages
訂單完成後即時交付
價格
Back to Top
栓塞保護裝置的全球市場預測 2023年:遠位過濾器、遠位閉塞、近位閉塞 Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023
出版日期: 2018年02月16日 內容資訊: 英文 174 Pages
簡介

全球栓塞保護裝置市場規模,預計從2018年的4億550萬美元到2023年達到6億490萬美元,在預測期間中預計為8.3%的年複合成長率。心血管、神經血管疾病的發病率的上升,資金、投資的增加,對技術性進步的栓塞保護裝置的銷售,及微創手術的需求擴大,預計促進該市場的成長。可是,產品的缺陷、回收預計某種程度抑制市場成長。

本報告提供全球栓塞保護裝置市場相關調查,市場規模的變化與預測,各種類、材料、用途、適應症、終端用戶的詳細分析、預測,市場的各種影響因素分析,地區、各主要國家趨勢,及主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 栓塞保護裝置市場上富有魅力的機會
  • 亞太地區的栓塞保護裝置市場:各適應症、各國
  • 栓塞保護裝置市場地區短評
  • 栓塞保護裝置市場:各類型
  • 栓塞保護裝置市場:地區混合

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動因素
    • 阻礙要素
    • 市場機會
    • 課題

第6章 栓塞保護裝置市場:各種類、材料

  • 栓塞保護裝置市場:各類型
    • 遠位過濾器設備
    • 遠位阻塞設備
    • 近位阻塞設備
  • 栓塞保護裝置市場:各材料
    • 鎳鈦合金
    • 聚氨酯

第7章 栓塞保護裝置市場:各用途

  • 簡介
  • 心血管疾病
  • 神經血管疾病
  • 末稍血管疾病

第8章栓塞保護裝置市場:各適應症

  • 簡介
  • 經皮冠狀動脈介入治療
  • 頸動脈疾病
  • 大隱靜脈移植
  • 經導管主動脈瓣置換
  • 其他的適應症

第9章栓塞保護裝置市場:各終端用戶

  • 簡介
  • 醫院
  • 門診外科中心

第10章 栓塞保護裝置市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 中東
  • 南美
  • 非洲

第11章 競爭情形

  • 簡介
  • 市場排行榜分析
  • 競爭情形

第12章 企業簡介

  • MEDTRONIC
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC
  • CORDIS (A CARDINAL HEALTH COMPANY)
  • CONTEGO MEDICAL
  • W. L. GORE & ASSOCIATES
  • SILK ROAD MEDICAL
  • CLARET MEDICAL
  • ALLIUM MEDICAL SOLUTIONS
  • ANGIOSLIDE

第13章 附錄

目錄
Product Code: MD 6012

"Global embolic protection devices market projected to grow at a CAGR of 8.3%"

The global embolic protection devices market is projected to reach USD 604.9 million by 2023 from USD 405.5 million in 2018, at a CAGR of 8.3% during the forecast period. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. However, product failure and recalls may restrain market growth to a certain extent.

"By type & material, the distal filters market & nitinol market held the largest market share in 2017"

By type, the global embolic protection devices market is segmented into distal filter devices, distal occlusion devices & proximal occlusion devices. By material, the global embolic protection devices market is segmented into plastic nitinol and polyurethane. In 2017, the distal filters segment dominated the embolic protection devices market by type and Nitinol dominated the embolic protection material market.

"By indication, the transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period"

On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by factors such as growing geriatric population, increasing obese population, increasing prevalence of aortic stenosis in heart patients, and rising demand for minimally invasive procedures.

"North America is expected to grow at the largest share during the forecast period (2018-2023)"

North America dominated the embolic protection devices market in 2017, followed by Europe. In North America, the US is expected to hold the largest share of the embolic protection devices market due to the rising prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding to develop novel products, and the strong presence of device manufacturers in the country.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-45%, Tier 2-30% and Tier 3-25%
  • By Designation - C-level-45%, Director Level-32%, Others-23%
  • By Region - North America-46%, Europe-27%, Asia-Pacific-20%, Latin America-4%, Middle East & Africa- 3%

The major players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

Research Coverage:

The embolic protection devices market in this report is segmented by type & material, application, indication, end user, and region. It provides detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers, acquisitions, product development, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the embolic protection devices market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-market share analysis of top players and company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the embolic protection devices market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest industry statistics and trends, allowing buyers to identify the high-growth product segments, potential customers, and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on embolic devices offered by the top players in the global embolic protection devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the embolic protection devices market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for embolic protection devices market across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global embolic protection devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global embolic protection devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
  • 1.4. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
      • 2.1.2.3. Breakdown of primary interviews
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN THE EMBOLIC PROTECTION DEVICES MARKET
  • 4.2. APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION AND COUNTRY
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET
  • 4.4. EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
  • 4.5. EMBOLIC PROTECTION DEVICES MARKET: REGIONAL MIX

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising incidence of cardiovascular & neurovascular diseases
      • 5.2.1.2. Funding and investments for r&d on embolic protection devices
      • 5.2.1.3. Technological advancements
      • 5.2.1.4. Rising demand for minimally invasive procedures
    • 5.2.2. RESTRAINT
      • 5.2.2.1. Product failure and recalls
    • 5.2.3. OPPORTUNITIE
      • 5.2.3.1. Growth opportunities in emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Stringent regulatory scenario and unfavorable government policies
      • 5.2.4.2. Dearth of skilled professionals

6. EMBOLIC PROTECTION DEVICES MARKET, BY TYPE & MATERIAL

  • 6.1. EMBOLIC PROTECTION DEVICES MARKET, BY TYPE
    • 6.1.1. DISTAL FILTER DEVICES
    • 6.1.2. DISTAL OCCLUSION DEVICES
    • 6.1.3. PROXIMAL OCCLUSION DEVICES
  • 6.2. EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL
    • 6.2.1. NITINOL
    • 6.2.2. POLYURETHANE

7. EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CARDIOVASCULAR DISEASES
  • 7.3. NEUROVASCULAR DISEASES
  • 7.4. PERIPHERAL VASCULAR DISEASES

8. EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION

  • 8.1. INTRODUCTION
  • 8.2. PERCUTANEOUS CORONARY INTERVENTION
  • 8.3. CAROTID ARTERY DISEASES
  • 8.4. SAPHENOUS VEIN GRAFT DISEASE
  • 8.5. TRANSCATHER AORTIC VALVE REPLACEMENT
  • 8.6. OTHER INDICATIONS

9. EMBOLIC PROTECTION DEVICES MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS
  • 9.3. AMBULATORY SURGICAL CENTERS

10. EMBOLIC PROTECTION DEVICES MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. UK
    • 10.3.4. SPAIN
    • 10.3.5. ITALY
    • 10.3.6. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. LATIN AMERICA
  • 10.6. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. RANKING FOR PLAYERS, 2017
  • 11.3. COMPETITIVE SCENARIO
    • 11.3.1. ACQUISITIONS
    • 11.3.2. PRODUCT LAUNCHES
    • 11.3.3. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.3.4. EXPANSIONS

12. COMPANY PROFILES (Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 12.1. MEDTRONIC
  • 12.2. ABBOTT LABORATORIES
  • 12.3. BOSTON SCIENTIFIC
  • 12.4. CORDIS (A CARDINAL HEALTH COMPANY)
  • 12.5. CONTEGO MEDICAL
  • 12.6. W. L. GORE & ASSOCIATES
  • 12.7. SILK ROAD MEDICAL
  • 12.8. CLARET MEDICAL
  • 12.9. ALLIUM MEDICAL SOLUTIONS
  • 12.10. ANGIOSLIDE

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: EMBOLIC PROTECTION DEVICES MARKET: (IMPACT ANALYSIS)
  • TABLE 2: PRODUCT APPROVALS IN THE EMBOLIC PROTECTION DEVICES MARKET, 2014-2017
  • TABLE 3: PRODUCT RECALLS IN THE EMBOLIC PROTECTION DEVICES MARKET (2011-2016)
  • TABLE 4: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 5: EMBOLIC PROTECTION DEVICES MARKET, BY VOLUME, 2016-2023 (THOUSAND UNITS)
  • TABLE 6: APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL FILTER DEVICES
  • TABLE 7: DISTAL FILTER DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: DISTAL FILTER DEVICES MARKET, BY VOLUME, 2016-2023 (THOUSAND UNITS)
  • TABLE 9: APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL OCCLUSION DEVICES
  • TABLE 10: DISTAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: DISTAL OCCLUSION DEVICES MARKET, BY VOLUME, 2016-2023 (THOUSAND UNITS)
  • TABLE 12: APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF PROXIMAL OCCLUSION DEVICES
  • TABLE 13: PROXIMAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: PROXIMAL OCCLUSION DEVICES MARKET, BY VOLUME, 2016-2023 (THOUSAND UNITS)
  • TABLE 15: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 16: NITINOL EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: POLYURETHANE EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 19: EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES
  • TABLE 20: EMBOLIC PROTECTION DEVICES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF NEUROVASCULAR DISEASES
  • TABLE 22: EMBOLIC PROTECTION DEVICES MARKET FOR NEUROVASCULAR DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES
  • TABLE 24: EMBOLIC PROTECTION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 26: EMBOLIC PROTECTION DEVICES MARKET FOR PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: EMBOLIC PROTECTION DEVICES MARKET FOR CAROTID ARTERY DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: EMBOLIC PROTECTION DEVICES MARKET FOR SAPHENOUS VEIN GRAFT DISEASE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: EMBOLIC PROTECTION DEVICES MARKET FOR TAVR, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: EMBOLIC PROTECTION DEVICES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 31: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 32: EMBOLIC PROTECTION DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: EMBOLIC PROTECTION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 38: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 40: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 41: US: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: US: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 43: US: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 44: US: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 45: US: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 46: CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 47: CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 48: CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 49: CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 50: CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 51: EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 52: EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 53: EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 54: EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 55: EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 56: EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 57: GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 59: GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 60: GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 61: GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 62: FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 63: FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 64: FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 65: FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 66: FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 67: UK: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: UK: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 69: UK: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 70: UK: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 71: UK: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 72: SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 74: SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 75: SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 76: SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 77: ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 79: ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 80: ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 81: ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 82: ROE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: ROE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 84: ROE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 85: ROE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 86: ROE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 87: APAC: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 88: APAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 89: APAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 90: APAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 91: APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 92: APAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 93: JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 95: JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 96: JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 97: JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 98: CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 100: CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 101: CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 102: CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 103: INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 104: INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 105: INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 106: INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 107: INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 108: ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 110: ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 111: ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 112: ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 113: LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 114: LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 115: LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 116: LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 117: LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 118: MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 119: MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 120: MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 121: MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016-2023 (USD MILLION)
  • TABLE 122: MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 123: RANK OF COMPANIES IN THE GLOBAL EMBOLIC PROTECTION DEVICES MARKET, 2017
  • TABLE 124: KEY ACQUISITIONS, JANUARY 2015 - DECEMBER 2017
  • TABLE 125: KEY PRODUCT LAUNCHES, JANUARY 2015- DECEMBER 2017
  • TABLE 126: KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, JANUARY 2015 - DECEMBER 2017
  • TABLE 127: KEY EXPANSIONS, JANUARY 2015 - DECEMBER 2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: DATA TRIANGULATION
  • FIGURE 3: EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 4: EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT MATERIAL, 2018 VS. 2023 (USD MILLION)
  • FIGURE 5: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 6: PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 7: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: GEOGRAPHICAL SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET
  • FIGURE 9: RISING INCIDENCE OF CARDIOVASCULAR AND NEUROVASCULAR DISEASES IS DRIVING MARKET GROWTH
  • FIGURE 10: JAPAN ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 11: THE US ACCOUNTED FOR THE LARGEST SHARE OF THE EMBOLIC PROTECTION DEVICES MARKET IN 2017
  • FIGURE 12: DISTAL FILTER DEVICES WILL CONTINUE TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET IN 2018-2023
  • FIGURE 13: ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: PREVALENCE OF CARDIOVASCULAR DISEASES, 2015-2035
  • FIGURE 15: DISTAL FILTER DEVICES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: NITINOL IS PROJECTED TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: CARDIOVASCULAR DISEASES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: EMBOLIC PROTECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 20: NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
  • FIGURE 21: EUROPE: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
  • FIGURE 22: APAC: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
  • FIGURE 23: KEY DEVELOPMENTS IN THE EMBOLIC PROTECTION DEVICES MARKET BETWEEN 2014 AND 2017
  • FIGURE 24: MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 25: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 26: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 27: CARDINAL HEALTH: COMPANY SNAPSHOT
  • FIGURE 28: ALLIUM MEDICAL SOLUTIONS: COMPANY SNAPSHOT
Back to Top